Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$29 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0580
D

Failure to Notify Resident Representative of New Antihypertensive Medication

Buffalo Grove, Illinois Survey Completed on 01-05-2026

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to notify a cognitively impaired resident’s health care power of attorney (POA) prior to initiating a new antihypertensive medication. The resident’s care plan dated 6/6/25 documented cognitive impairment related to dementia and multiple sclerosis, noted that she was very forgetful, and directed that all information be provided directly to her advocate. A POA form dated 9/12/24 identified a family member (V7) as the resident’s POA. Physician progress notes and a physician order dated 8/8/25 showed the resident was started on Losartan 25 mg daily for a new diagnosis of hypertension, and the physician documented that the new medication was discussed with the resident. However, there was no documentation that the POA was notified of the resident’s elevated blood pressures or the initiation of Losartan. On interview, the POA stated she was not informed that the resident had high blood pressure or that Losartan had been started until she spoke with a cardiology nurse practitioner on 12/17/25, despite being in the facility at least twice a week and having repeatedly requested to be notified of any changes, including medications. A cardiology note dated 12/17/25 confirmed that the nurse practitioner contacted the POA, who reported she was unaware the resident was taking Losartan. During observation on 1/5/26, the resident was awake but confused to place and time, unable to state the month, and did not know if she was on a medication for high blood pressure, stating that staff talk to her family member about all her medications. Social services staff described the resident as confused and forgetful with impaired short-term memory and confirmed that the POA was very involved and had requested to be informed of any changes. The DON stated that when a resident is started on a new medication, the resident and/or representative should receive education and consent prior to administration, and acknowledged that the cognitively impaired resident’s representative, who had requested notification of all changes, was not notified prior to starting Losartan.

Long-term care team reviewing survey readiness and plan of correction

We Help Long-Term Care Teams Stay Survey-Ready

We process and analyze inspection reports and plan of correction using AI to extract insights and trends so providers can improve care quality and stay ahead of compliance risks.

Discover our solutions:

An unhandled error has occurred. Reload 🗙